Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis-Reference-Cited by-同舟云学术

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis

Published:2017-04 Issue:1 Volume:3 Page:e000430
ISSN:2056-5933
Container-title:RMD Open
language:en
Short-container-title:RMD Open

Author:

Braun Jürgen,Baraliakos Xenofon,Hermann Kay-Geert,Landewé Robert,Machado Pedro M,Maksymowych Walter P,Davies Owen,Hoepken Bengt,Nurminen Tommi,Stach Christian,van der Heijde Désirée

Publisher

BMJ

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference38 articles.

1. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria;van der Linden;Arthritis Rheum,1984

2. Magnetic resonance imaging of sacroiliitis in patients with spondyloarthritis: correlation with anatomy and histology;Hermann;Rofo,2014

3. [MRI examinations for axial and peripheral spondyloarthritis];Baraliakos;Z Rheumatol,2012

4. Hamilton L, Barkham N, Bhalla A, et al. BSR and BPHR Guideline for the Treatment of Axial Spondyloarthritis (Including Ankylosing Spondylitis) with Biologics. Rheumatology (Oxford) 2017;56:313–6. https://academic.oup.com/rheumatology/article/56/2/313/2631549/BSR-and-BHPR-guideline-for-the-treatment-of-axial.

5. Old and new treatment targets in axial spondyloarthritis;Rios Rodriguez;RMD Open,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis;RMD Open;2024-08

2. Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial;Rheumatology and Therapy;2024-04-18

3. Certolizumab pegol in the treatment of axial spondyloarthritis;Immunotherapy;2024-03-26

4. Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis;RMD Open;2024-02

5. Effects of disease-modifying anti-rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: a systematic review and meta-analysis;Clinical Rheumatology;2023-12-29